FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1589001000168101: natalizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2022. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4658111000168118 natalizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4658121000168113 natalizumab 150 mg/mL injection, syringe en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
natalizumab 150 mg/mL injection, syringe Is a medicinal product unit of use true Inferred relationship Some
natalizumab 150 mg/mL injection, syringe Is a natalizumab true Inferred relationship Some
natalizumab 150 mg/mL injection, syringe has manufactured dose form injection true Inferred relationship Some
natalizumab 150 mg/mL injection, syringe has unit of use syringe true Inferred relationship Some 1564180972
natalizumab 150 mg/mL injection, syringe has intended active ingredient natalizumab true Inferred relationship Some 98570905
natalizumab 150 mg/mL injection, syringe has Australian BoSS natalizumab true Inferred relationship Some 98570905
Inbound Relationships Type Active Source Characteristic Refinability Group
Tysabri 150 mg/mL injection, 1 mL syringe Is a True natalizumab 150 mg/mL injection, syringe Inferred relationship Some
natalizumab 150 mg/mL injection, 2 x 1 mL syringes has MPUU True natalizumab 150 mg/mL injection, syringe Inferred relationship Some 1436241030

Reference Sets

Medicinal product unit of use reference set

Back to Start